Detalhe da pesquisa
1.
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292514
2.
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.
Clin Cancer Res
; 27(14): 4054-4065, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903200
3.
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.
Clin Cancer Res
; 27(14): 4036-4053, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33771854
4.
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.
Sci Transl Med
; 12(534)2020 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32161104
5.
Tonic and phasic pyloric activity in response to CCK-octapeptide.
Dig Dis Sci
; 53(4): 905-11, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18270827